malaysiasun.com·3 min read·hard
Led Cancer Screening Innovation in the Global Spotlight
✦AI Summary
Gene Solutions announced a major milestone for its AI-powered blood test, SPOT-MAS 10, following a large-scale study of over 84,000 individuals. The technology has received FDA Breakthrough Device Designation and is gaining international recognition.
Singapore, July 7: Gene Solutions , a biotechnology company advancing genomic solutions for cancer detection and precision oncology, today announced a major global milestone for SPOT-MAS 10 , its AI-powered, multi-omic blood-based test for multi-cancer screening.
healthsciencebusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in